OSHA Plus Demo

Why Is This Training Provided?: 

Subjects Covered In This Training Program Why Is This Training Provided? OSHA mandates training on OSHA regulations for ALL workers at the time of initial assignment to tasks where occupational exposure may take place and at least annually thereafter.

Bloodborne Pathogens: Transmission in Healthcare Settings: 

Bloodborne Pathogens: Transmission in Healthcare Settings In the healthcare setting, bloodborne pathogen transmission occurs predominantly by percutaneous or mucosal exposure of workers to the blood or body fluids of infected patients. Occupational exposures that may result in HIV, HBV, or HCV transmission include needlestick and other sharps injuries; direct inoculation of virus into cutaneous scratches, skin lesions, abrasions, or burns; and inoculation of virus onto mucosal surfaces of the eyes, nose, or mouth through accidental splashes. NOTE : HIV, HBV, and HCV do not spontaneously penetrate intact skin, and airborne transmission of these viruses does not occur.

Hepatitis B Vaccination: Methods of Compliance: 

Hepatitis B Vaccination : Methods of Compliance Hepatitis B vaccination shall be made available after the employee has received training on the hepatitis B vaccine and within 10 working days of initial assignment to all employees who have occupational exposure unless the employee has previously received the complete hepatitis B vaccination series, antibody testing has revealed that the employee is immune, or the vaccine is contraindicated for medical reasons. If the employee initially declines hepatitis B vaccination but at a later date while still covered under the standard decides to accept the vaccination, the employer shall make available the hepatitis B vaccination at that time. The employer shall assure that employees who decline to accept hepatitis B vaccination offered by the employer sign a mandatory Hepatitis B Vaccine Declination Form.

Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings:: 

Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings: TB Infection-Control Program for Settings in Which Patients with Suspected or Confirmed TB Disease Are Expected To Be Encountered: Source: MMWR, December 30, 2005 Assign supervisory responsibility for the TB infection-control program Develop a written TB infection- control plan Conduct a problem evaluation if a case of suspected or confirmed TB disease is not promptly recognized and appropriate airborne precautions not initiated, or if administrative, environmental, or respiratory-protection controls fail Perform a contact investigation in collaboration with the local or state health department Collaborate with the local or state health department to develop administrative controls Implement and maintain environmental controls Perform ongoing training and education for Healthcare Workers Create a plan for accepting patients who have suspected or confirmed TB disease if they are transferred from another setting Implement a respiratory- protection program

QuantiFERON-TB Gold:: 

QuantiFERON-TB Gold: Source: Division of Tuberculosis Elimination, CDC, 11/16/07 The QuantiFERON ® -TB Gold test (QFT-G) is a whole- blood test for use as an aid in diagnosing Mycobacterium tuberculosis infection, including latent tuberculosis infection (LTBI) and tuberculosis (TB) disease. This test was approved by the U.S. Food and Drug Administration (FDA) in 2005. Requires a single patient visit to draw a blood sample. Results can be available within 24 hours. Does not boost responses measured by subsequent tests, which can happen with tuberculin skin tests (TST). Is not subject to reader bias that can occur with TST. Is not affected by prior BCG (bacille Calmette-Guérin) vaccination. What are the advantages?